314 related articles for article (PubMed ID: 26595903)
1. Visit-to-visit variability in LDL- and HDL-cholesterol is associated with adverse events after ST-segment elevation myocardial infarction: A 5-year follow-up study.
Boey E; Gay GM; Poh KK; Yeo TC; Tan HC; Lee CH
Atherosclerosis; 2016 Jan; 244():86-92. PubMed ID: 26595903
[TBL] [Abstract][Full Text] [Related]
2. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.
Lee EY; Yang Y; Kim HS; Cho JH; Yoon KH; Chung WS; Lee SH; Chang K
Atherosclerosis; 2018 Dec; 279():1-9. PubMed ID: 30359786
[TBL] [Abstract][Full Text] [Related]
3. Relationship between low-density lipoprotein levels on admission and 1-year outcome in patients with acute ST-segment-elevation myocardial infarction.
Sun YJ; Li YZ; Jiang DM; Zhang B; Gao Y; Zhang ZH; Qi GX
Kaohsiung J Med Sci; 2013 Apr; 29(4):206-13. PubMed ID: 23541266
[TBL] [Abstract][Full Text] [Related]
4. Impact of low level of high-density lipoprotein-cholesterol sampled in overnight fasting state on the clinical outcomes in patients with acute myocardial infarction (difference between ST-segment and non-ST-segment-elevation myocardial infarction).
Ji MS; Jeong MH; Ahn YK; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
J Cardiol; 2015 Jan; 65(1):63-70. PubMed ID: 25242301
[TBL] [Abstract][Full Text] [Related]
5. Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus.
Joo HJ; Cho SA; Hong SJ; Hur SH; Bae JH; Choi DJ; Ahn YK; Park JS; Choi RK; Choi D; Kim JH; Han KR; Park HS; Choi SY; Yoon JH; Kwon HC; Rha SW; Hwang KK; Jung KT; Oh SK; Lee JH; Shin ES; Kim KS; Kim HS; Lim DS
Lipids Health Dis; 2016 Nov; 15(1):197. PubMed ID: 27863493
[TBL] [Abstract][Full Text] [Related]
6. Is non-HDL-cholesterol a better predictor of long-term outcome in patients after acute myocardial infarction compared to LDL-cholesterol? : a retrospective study.
Wongcharoen W; Sutthiwutthichai S; Gunaparn S; Phrommintikul A
BMC Cardiovasc Disord; 2017 Jan; 17(1):10. PubMed ID: 28056802
[TBL] [Abstract][Full Text] [Related]
7. Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial.
Bangalore S; Breazna A; DeMicco DA; Wun CC; Messerli FH;
J Am Coll Cardiol; 2015 Apr; 65(15):1539-48. PubMed ID: 25881936
[TBL] [Abstract][Full Text] [Related]
8. Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
Waters DD; Bangalore S; Fayyad R; DeMicco DA; Laskey R; Melamed S; Barter PJ
J Clin Lipidol; 2018; 12(2):356-366. PubMed ID: 29310989
[TBL] [Abstract][Full Text] [Related]
9. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
[TBL] [Abstract][Full Text] [Related]
10. Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol ≤ 50 mg/dl.
Piao ZH; Jin L; Kim JH; Ahn Y; Kim YJ; Cho MC; Kim CJ; Kim HS; Liu B; Jeong MH;
Am J Cardiol; 2017 Jul; 120(2):174-180. PubMed ID: 28532771
[TBL] [Abstract][Full Text] [Related]
11. Biomarker evaluation as a potential cause of gender differences in obesity paradox among patients with STEMI.
Baumann S; Koepp J; Becher T; Huseynov A; Bosch K; Behnes M; Fastner C; El-Battrawy I; Renker M; Lang S; Weiß C; Borggrefe M; Lehmann R; Akin I
Cardiovasc Revasc Med; 2016 Mar; 17(2):88-94. PubMed ID: 26895953
[TBL] [Abstract][Full Text] [Related]
12. Relation of Low-Density Lipoprotein Cholesterol With Microvascular Injury and Clinical Outcome in Revascularized ST-Elevation Myocardial Infarction.
Reindl M; Reinstadler SJ; Feistritzer HJ; Theurl M; Basic D; Eigler C; Holzknecht M; Mair J; Mayr A; Klug G; Metzler B
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29018020
[TBL] [Abstract][Full Text] [Related]
13. Visit-to-visit variability in low-density lipoprotein cholesterol is associated with adverse events in non-obstructive coronary artery disease.
Gu J; Yin ZF; Pan JA; Zhang JF; Wang CQ
Anatol J Cardiol; 2019 Sep; 22(3):117-124. PubMed ID: 31475951
[TBL] [Abstract][Full Text] [Related]
14. [Impact of high-density lipoprotein levels at hospital admission on the outcome of patients with acute ST-segment elevation myocardial infarction].
Sun YJ; Jiang DM; Zhang B; Gao Y; Li YZ; Yu HJ; Qi GX
Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Mar; 33(3):332-6. PubMed ID: 22613390
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention.
Oduncu V; Erkol A; Kurt M; Tanboğa IH; Karabay CY; Şengül C; Bulut M; Özveren O; Fotbolcu H; Akgün T; Türkyilmaz E; Kırma C
Int J Cardiol; 2013 Jul; 167(2):458-63. PubMed ID: 22305817
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of lipoprotein indices for residual risk of acute myocardial infarction and sudden death in men with low-density lipoprotein cholesterol levels <120 mg/dl.
Tanaka F; Makita S; Onoda T; Tanno K; Ohsawa M; Itai K; Sakata K; Omama S; Yoshida Y; Ogasawara K; Ogawa A; Ishibashi Y; Kuribayashi T; Okayama A; Nakamura M;
Am J Cardiol; 2013 Oct; 112(8):1063-8. PubMed ID: 23831165
[TBL] [Abstract][Full Text] [Related]
17. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
18. Impact of low high-density lipoproteins on in-hospital events and one-year clinical outcomes in patients with non-ST-elevation myocardial infarction acute coronary syndrome treated with drug-eluting stent implantation.
Wolfram RM; Brewer HB; Xue Z; Satler LF; Pichard AD; Kent KM; Waksman R
Am J Cardiol; 2006 Sep; 98(6):711-7. PubMed ID: 16950168
[TBL] [Abstract][Full Text] [Related]
19. High-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after percutaneous coronary intervention: a report from the CREDO-Kyoto registry cohort-2.
Izuhara M; Ono K; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Shizuta S; Tada T; Tazaki J; Horie T; Kuwabara Y; Baba O; Nishino T; Kita T; Kimura T;
Atherosclerosis; 2015 Oct; 242(2):632-8. PubMed ID: 26022139
[TBL] [Abstract][Full Text] [Related]
20. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.
Liao KP; Liu J; Lu B; Solomon DH; Kim SC
Arthritis Rheumatol; 2015 May; 67(8):2004-10. PubMed ID: 25917955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
